Modulight Oyj
OMXH:MODU
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.744
1.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Modulight Oyj
Total Liabilities & Equity
Modulight Oyj
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Modulight Oyj
OMXH:MODU
|
Total Liabilities & Equity
€64m
|
CAGR 3-Years
48%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
Total Liabilities & Equity
€132.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
22%
|
|
|
B
|
Bioretec Oy
OMXH:BRETEC
|
Total Liabilities & Equity
€10.7m
|
CAGR 3-Years
40%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
Total Liabilities & Equity
€29.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nexstim Oyj
OMXH:NXTMH
|
Total Liabilities & Equity
€11.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biohit Oyj
OMXH:BIOBV
|
Total Liabilities & Equity
€14.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
Modulight Oyj
Glance View
Modulight Oy designs, markets and manufactures laser products semiconductor, laser modules and other laser products. The company is headquartered in Tampere, Lansi-Suomen and currently employs 74 full-time employees. The company went IPO on 2021-09-30. Modulight provides biomedical lasers for medical applications, including oncology, ophthalmology and genetics, as well as other diagnostics for medical and biomedical segments. Additionally, the Company offers customized biomedical laser solutions, including wavelength, optical power and laser output beam engineering enabled by its own fabrication plant and semiconductor process. Modulight Oyj is the Group's Parent Company. The Company’s subsidiaries include Modulight China Export A Oy, Leaptek Photonics Oy, and Modulight USA Inc.
See Also
What is Modulight Oyj's Total Liabilities & Equity?
Total Liabilities & Equity
64m
EUR
Based on the financial report for Dec 31, 2023, Modulight Oyj's Total Liabilities & Equity amounts to 64m EUR.
What is Modulight Oyj's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
44%
Over the last year, the Total Liabilities & Equity growth was -18%. The average annual Total Liabilities & Equity growth rates for Modulight Oyj have been 48% over the past three years , 44% over the past five years .
You don't have any saved screeners yet
